Study to Evaluate the Efficacy and Safety of JTE-451 in Subjects With Moderate to Severe Plaque Psoriasis
Clinical trial NCT03832738 · COMPLETED
Trial details
- NCT number
- NCT03832738
- Sponsor
- Akros Pharma Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-17
- Primary completion
- 2020-03-13
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.